Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abo

Showing results (111-120 of 296) with videos related to

Pageof 30
Sort By:
Blood|February 1, 1984
Natural killer cells suppress human erythroid stem cell proliferation in vitroK F Mangan, M E Hartnett, S A Matis, et al.
Blood|April 1, 1985
Expression of the Chediak-Higashi lysosomal abnormality in human peripheral blood lymphocyte subpopulationsC E Grossi, W M Crist, T Abo, et al.
Scandinavian Journal of Immunology|September 1, 1984
Characterization of a subset of human natural killer cells that express OKM1 but lack HNK-1 (Leu-7) antigensR Marolda, A B Tilden, T Abo, et al.
International Journal of Pharmaceutics|March 5, 2024
Doxorubicin loaded cerium substituted hydroxyapatite nanoparticles: A promising new therapeutic approach for bone regeneration, doxorubicin delivery, and cancer treatmentMona Moaness, Sahar M Mousa, Mahmoud T Abo-Elfadl, et al.
Clinical and Experimental Immunology|March 5, 1998
Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory roleK Arai, S Yamamura, S Seki, et al.
The Journal of Clinical Investigation|July 1, 1982
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphologyT Abo, J C Roder, W Abo, et al.
Environmental Toxicology and Pharmacology|June 25, 2019
Evaluation of lapatinib cytotoxicity and genotoxicity on MDA-MB-231 breast cancer cell lineMona A M Abo-Zeid, Mahmoud T Abo-Elfadl, Amira M Gamal-Eldeen
RSC Advances|November 9, 2022
Evaluation of cytotoxic properties of two fluorescent <i>fac</i>-Re(CO)<sub>3</sub> complexes bearing an <i>N</i>,<i>N</i>-bidentate benzimidazole coligandAhmed M Mansour, Nourhan M Ibrahim, Ahmad M Farag, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 22, 2023
Development of a Defined Approach for Eye hazard identification of chemicals having surfactant properties according to the three UN GHS categoriesN Alépée, E Adriaens, T Abo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Identification and characterization of effector lymphocytes lysing autologous tumor cells]K Kumagai, M Fujii, T Abo, et al.
Pageof 30

Showing results (111-120 of 296) with videos related to

Sort By:
Pageof 30
Blood|February 1, 1984
Natural killer cells suppress human erythroid stem cell proliferation in vitroK F Mangan, M E Hartnett, S A Matis, et al.
Blood|April 1, 1985
Expression of the Chediak-Higashi lysosomal abnormality in human peripheral blood lymphocyte subpopulationsC E Grossi, W M Crist, T Abo, et al.
Scandinavian Journal of Immunology|September 1, 1984
Characterization of a subset of human natural killer cells that express OKM1 but lack HNK-1 (Leu-7) antigensR Marolda, A B Tilden, T Abo, et al.
International Journal of Pharmaceutics|March 5, 2024
Doxorubicin loaded cerium substituted hydroxyapatite nanoparticles: A promising new therapeutic approach for bone regeneration, doxorubicin delivery, and cancer treatmentMona Moaness, Sahar M Mousa, Mahmoud T Abo-Elfadl, et al.
Clinical and Experimental Immunology|March 5, 1998
Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory roleK Arai, S Yamamura, S Seki, et al.
The Journal of Clinical Investigation|July 1, 1982
Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphologyT Abo, J C Roder, W Abo, et al.
Environmental Toxicology and Pharmacology|June 25, 2019
Evaluation of lapatinib cytotoxicity and genotoxicity on MDA-MB-231 breast cancer cell lineMona A M Abo-Zeid, Mahmoud T Abo-Elfadl, Amira M Gamal-Eldeen
RSC Advances|November 9, 2022
Evaluation of cytotoxic properties of two fluorescent <i>fac</i>-Re(CO)<sub>3</sub> complexes bearing an <i>N</i>,<i>N</i>-bidentate benzimidazole coligandAhmed M Mansour, Nourhan M Ibrahim, Ahmad M Farag, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 22, 2023
Development of a Defined Approach for Eye hazard identification of chemicals having surfactant properties according to the three UN GHS categoriesN Alépée, E Adriaens, T Abo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Identification and characterization of effector lymphocytes lysing autologous tumor cells]K Kumagai, M Fujii, T Abo, et al.
Pageof 30